DocDollars

Pfizer Inc.

NY · United States · Reporting entity ID 100000000286

Total reported 2019–2025
$5.12B
#1 of 2,960 reporting companies — 6.2% of all reported industry payments
$513.2M in general payments across 2,932,769 records, plus $4.61B in research funding across 269,883 records.

How it breaks down

General payments $513,229,393
Research funding $4,611,059,125

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pfizer Inc. reported $5.12B to US doctors and teaching hospitals from 2019 to 2025, ranking #1 of 2,960 reporting companies. 90% of that was research funding and 10% general payments such as consulting, speaking, food and travel. 2,932,769 general payment records and 269,883 research records were filed.

Common questions about Pfizer Inc.

How much has Pfizer Inc. paid US doctors?

Pfizer Inc. reported $5,124,288,518 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $513,229,393 in general payments, $4,611,059,125 in research funding.

How does Pfizer Inc. rank among drug and device companies?

It ranks #1 of 2,960 reporting entities by total reported value, about 6.2% of all industry payments in the dataset.

Does a payment from Pfizer Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.